You are here:
Biotech & Pharma — Patented Technologies
Last Updated:February 26, 2026
About This Investor
JP-B-648
With roots in Japan, this investor is building pipeline coverage and invites relevant teasers. M&A rationale centers on Expand existing businesses overseas. They are specifically targeting: Manufacturing of eye care, skin care products, oral medications, and regenerative medicine – related products Only companies of a certain size and with patents or special technologies will be…
Biotech / Pharmaceuticals
Worldwide
Overseas Expansion
$130.8M - $654.2M
Majority/100% | Minority ok if step-up to majority feasible
Request Full Investor Profile
Similar Investors
JP-B-547
They are currently building a shortlist and welcome relevant introductions.
Facility Management
Malaysia, Singapore
Overseas Expansion
$3.27M - $9.81M
Majority / 100%
JP-B-312
Opportunity mandate: From Japan, this investor is open to qualified
Media & Entertainment
Asia
Strategic Expansion
$654K - $6.54M
Minority
JP-B-360
Japan – based, this investor is building pipeline coverage and
Industrial Manufacturing
Worldwide
Strategic Expansion
$654K - $32.7M
Minority / Majority / 100% | Revenue ≥ USD 13.1M | Stable op profit